{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:05:14Z","timestamp":1781593514422,"version":"3.54.5"},"reference-count":40,"publisher":"Tsinghua University Press","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.26599\/1671-5411.2024.09.008","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T02:38:44Z","timestamp":1730774324000},"page":"831-845","source":"Crossref","is-referenced-by-count":3,"title":["Valvular heart disease and cardiomyopathy in China: epidemiology and current treatments"],"prefix":"10.26599","volume":"21","author":[{"given":"Sheng-Shou","family":"HU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12872-021-02154-8","article-title":"Current status and etiology of valvular heart disease in China: a population-based survey","volume":"21","author":"Y Yang","year":"2021","unstructured":"Y Yang. Current status and etiology of valvular heart disease in China: a population-based survey. 2021, 21: 339.","journal-title":"BMC Cardiovasc Disord"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1536\/ihj.19-467","article-title":"Distribution patterns of valvular and vascular complications in bicuspid aortic valve","volume":"61","author":"YS Wang","year":"2020","unstructured":"YS Wang. Distribution patterns of valvular and vascular complications in bicuspid aortic valve. 2020, 61: 273-280.","journal-title":"Int Heart J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1155\/2021\/9982569","article-title":"Prevalence and modifiable risk factors of degenerative valvular heart disease among elderly population in southern China","volume":"18","author":"SF He","year":"2021","unstructured":"SF He. Prevalence and modifiable risk factors of degenerative valvular heart disease among elderly population in southern China. 2021, 18: 523-533.","journal-title":"J Geriatr Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"9982569","DOI":"10.1155\/2021\/9982569","article-title":"The evolving epidemiology of elderly with degenerative valvular heart disease: The Guangzhou (China) Heart Study","volume":"2021","author":"SF He","year":"2021","unstructured":"SF He. The evolving epidemiology of elderly with degenerative valvular heart disease: The Guangzhou (China) Heart Study. 2021, 2021: 9982569.","journal-title":"Biomed Res Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"E486","DOI":"10.1532\/hsf.2369","article-title":"Baseline and outcome characteristics of multiple valve surgery compared with single valve procedures in mainland China: a multicenter experience","volume":"22","author":"L Jin","year":"2019","unstructured":"L Jin. Baseline and outcome characteristics of multiple valve surgery compared with single valve procedures in mainland China: a multicenter experience. 2019, 22: E486-E493.","journal-title":"Heart Surg Forum"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"111753","DOI":"10.1016\/j.ecoenv.2020.111753","article-title":"Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study","volume":"209","author":"YX Pang","year":"2021","unstructured":"YX Pang. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study. 2021, 209: 111753.","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1111\/jocs.15020","article-title":"Left atrial appendage exclusion is effective in reducing postoperative stroke after mitral valve replacement","volume":"35","author":"SL Jiang","year":"2020","unstructured":"SL Jiang. Left atrial appendage exclusion is effective in reducing postoperative stroke after mitral valve replacement. 2020, 35: 3395-3402.","journal-title":"J Card Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jtcvs.2020.01.053","article-title":"Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease","volume":"162","author":"JT Fu","year":"2021","unstructured":"JT Fu. Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease. 2021, 162: 72-82,e7.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.athoracsur.2020.03.112","article-title":"Transcatheter aortic valve replacement in aortic regurgitation","volume":"110","author":"LL Liu","year":"2020","unstructured":"LL Liu. Transcatheter aortic valve replacement in aortic regurgitation. 2020, 110: 1959-1966.","journal-title":"Ann Thorac Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1097\/CM9.0000000000001882","article-title":"Characteristics and outcomes following transcatheter aortic valve replacement in China: a report from China aortic valve transcatheter replacement registry (CARRY)","volume":"134","author":"YM Li","year":"2021","unstructured":"YM Li. Characteristics and outcomes following transcatheter aortic valve replacement in China: a report from China aortic valve transcatheter replacement registry (CARRY). 2021, 134: 2678-2684.","journal-title":"Chin Med J (Engl)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/heartjnl-2020-318199","article-title":"Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation","volume":"107","author":"FL Lu","year":"2021","unstructured":"FL Lu. Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation. 2021, 107: 1664-1670.","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13019-020-01192-1","article-title":"Simplified, minimally invasive, beating-heart technique for redo isolated tricuspid valve surgery","volume":"15","author":"S Lu","year":"2020","unstructured":"S Lu. Simplified, minimally invasive, beating-heart technique for redo isolated tricuspid valve surgery. 2020, 15: 146-151.","journal-title":"J Cardiothorac Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.athoracsur.2020.01.009","article-title":"Multicenter comparison of percutaneous and surgical pulmonary valve replacement in large RVOT","volume":"110","author":"WB Ou-Yang","year":"2020","unstructured":"WB Ou-Yang. Multicenter comparison of percutaneous and surgical pulmonary valve replacement in large RVOT. 2020, 110: 980-987.","journal-title":"Ann Thorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.21037\/apm-21-2005","article-title":"Decade-long mitral valve surgery trends and rheumatic heart disease: a review of mitral valve surgery in a large Chinese cardiovascular center","volume":"11","author":"YQ Jiao","year":"2022","unstructured":"YQ Jiao. Decade-long mitral valve surgery trends and rheumatic heart disease: a review of mitral valve surgery in a large Chinese cardiovascular center. 2022, 11: 1160-1169.","journal-title":"Ann Palliat Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101466","DOI":"10.1016\/j.eclinm.2022.101466","article-title":"Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study","volume":"49","author":"WX Chan","year":"2022","unstructured":"WX Chan. Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study. 2022, 49: 101466.","journal-title":"EClinicalMedicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"YB Zou","year":"2004","unstructured":"YB Zou. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. 2004, 116: 14-18.","journal-title":"Am J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ejhf.144","article-title":"Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy","volume":"16","author":"JZ Wang","year":"2014","unstructured":"JZ Wang. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy. 2014, 16: 950-957.","journal-title":"Eur J Heart Fail"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/CIRCULATIONAHA.120.050384","article-title":"An East Asian-specific common variant in TNNI3 predisposes to hypertrophic cardiomyopathy","volume":"142","author":"GX Wu","year":"2020","unstructured":"GX Wu. An East Asian-specific common variant in TNNI3 predisposes to hypertrophic cardiomyopathy. 2020, 142: 2086-2089.","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCGENETICS.113.000122","article-title":"Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"JR Bao","year":"2013","unstructured":"JR Bao. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy. 2013, 6: 552-556.","journal-title":"Circ Cardiovasc Genet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2018.06.105","article-title":"A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype","volume":"274","author":"L Chen","year":"2019","unstructured":"L Chen. A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype. 2019, 274: 263-270.","journal-title":"Int J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13642","author":"","unstructured":"","journal-title":"null"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"617561","DOI":"10.3389\/fcvm.2020.617561","article-title":"Genetics and clinical features of noncompaction cardiomyopathy in the fetal population","volume":"7","author":"HR Sun","year":"2021","unstructured":"HR Sun. Genetics and clinical features of noncompaction cardiomyopathy in the fetal population. 2021, 7: 617561.","journal-title":"Front Cardiovasc Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.hrthm.2020.04.017","article-title":"Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology\/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy","volume":"17","author":"J Liu","year":"2020","unstructured":"J Liu. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology\/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy. 2020, 17: 1658-1663.","journal-title":"Heart Rhythm"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cjca.2019.11.009","article-title":"A novel risk stratification score for sudden cardiac death prediction in middle-aged, nonischemic dilated cardiomyopathy patients: The ESTIMATED score","volume":"36","author":"XF Li","year":"2020","unstructured":"XF Li. A novel risk stratification score for sudden cardiac death prediction in middle-aged, nonischemic dilated cardiomyopathy patients: The ESTIMATED score. 2020, 36: 1121-1129.","journal-title":"Can J Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02219-7","author":"","unstructured":"","journal-title":"null"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"766571","DOI":"10.3389\/fcvm.2021.766571","article-title":"Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: A 10-year, single-center experience","volume":"8","author":"HD Zhang","year":"2021","unstructured":"HD Zhang. Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: A 10-year, single-center experience. 2021, 8: 766571.","journal-title":"Front Cardiovasc Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e023152","DOI":"10.1161\/JAHA.121.023152","article-title":"Impact of body mass index on postoperative atrial fibrillation in patients with hypertrophic cardiomyopathy undergoing septal myectomy","volume":"11","author":"J Zhang","year":"2022","unstructured":"J Zhang. Impact of body mass index on postoperative atrial fibrillation in patients with hypertrophic cardiomyopathy undergoing septal myectomy. 2022, 11: e023152.","journal-title":"J Am Heart Assoc"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/1076029619866909","author":"","unstructured":"","journal-title":"null"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518801478","author":"","unstructured":"","journal-title":"null"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/ehjci\/jeaa144","article-title":"Prognostic value of left ventricular remodelling index in idiopathic dilated cardiomyopathy","volume":"22","author":"YW Xu","year":"2021","unstructured":"YW Xu. Prognostic value of left ventricular remodelling index in idiopathic dilated cardiomyopathy. 2021, 22: 1197-1207.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1038\/s41467-022-31548-1","article-title":"Cardiac disruption of SDHAF4-mediated mitochondrial complex II assembly promotes dilated cardiomyopathy","volume":"13","author":"X Wang","year":"2022","unstructured":"X Wang. Cardiac disruption of SDHAF4-mediated mitochondrial complex II assembly promotes dilated cardiomyopathy. 2022, 13: 3947.","journal-title":"Nat Commun"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/CIRCULATIONAHA.121.055781","article-title":"Rewiring of 3D chromatin topology orchestrates transcriptional reprogramming and the development of human dilated cardiomyopathy","volume":"145","author":"Y Feng","year":"2022","unstructured":"Y Feng. Rewiring of 3D chromatin topology orchestrates transcriptional reprogramming and the development of human dilated cardiomyopathy. 2022, 145: 1663-1683.","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e012989","DOI":"10.1161\/JAHA.119.012989","article-title":"Early left ventricular involvement detected by cardiovascular magnetic resonance feature tracking in arrhythmogenic right ventricular cardiomyopathy: The effects of left ventricular late gadolinium enhancement and right ventricular dysfunction","volume":"8","author":"XY Chen","year":"2019","unstructured":"XY Chen. Early left ventricular involvement detected by cardiovascular magnetic resonance feature tracking in arrhythmogenic right ventricular cardiomyopathy: The effects of left ventricular late gadolinium enhancement and right ventricular dysfunction. 2019, 8: e012989.","journal-title":"J Am Heart Assoc"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/europace\/euz026","article-title":"Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure","volume":"21","author":"K Chen","year":"2019","unstructured":"K Chen. Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure. 2019, 21: 970-977.","journal-title":"Europace"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"eaay8329","DOI":"10.1126\/scitranslmed.aay8329","article-title":"Elevated plasma \u03b2-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy","volume":"12","author":"JP Song","year":"2020","unstructured":"JP Song. Elevated plasma \u03b2-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy. 2020, 12: eaay8329.","journal-title":"Sci Transl Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ahj.2021.10.187","article-title":"Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy","volume":"244","author":"D Akdis","year":"2022","unstructured":"D Akdis. Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy. 2022, 244: 66-76.","journal-title":"Am Heart J"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/eurheartj\/ehz172","article-title":"A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression","volume":"40","author":"L Chen","year":"2019","unstructured":"L Chen. A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression. 2019, 40: 1690-1703.","journal-title":"Eur Heart J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/eurheartj\/ehz253","article-title":"Multiple facets of arrhythmogenic cardiomyopathy: the Fuwai classification of a unique disease based on clinical features, histopathology, and genotype","volume":"40","author":"F Duru","year":"2019","unstructured":"F Duru. Multiple facets of arrhythmogenic cardiomyopathy: the Fuwai classification of a unique disease based on clinical features, histopathology, and genotype. 2019, 40: 1704-1706.","journal-title":"Eur Heart J"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s44161-022-00057-1","article-title":"Metabolic characterization of hypertrophic cardiomyopathy in human heart","volume":"1","author":"W Wang","year":"2022","unstructured":"W Wang. Metabolic characterization of hypertrophic cardiomyopathy in human heart. 2022, 1: 445-461.","journal-title":"Nat Cardiovasc Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"M Zhou","year":"2022","unstructured":"M Zhou. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy. 2022, 7: 529-538.","journal-title":"JAMA Cardiol"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T02:38:46Z","timestamp":1730774326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2024.09.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2024.09.008","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}